IGI Laboratories, Inc., a New Jersey-based specialty generic pharmaceutical company, announced that it will adopt Teligent, Inc. as its new name and will begin trading under a new symbol – TLGT – after ringing the NASDAQ Opening Bell on October 26, 2015.
''Our new name captures the energy and passion that our people feel about our future,'' said Jason Grenfell-Gardner, the Company's President and Chief Executive Officer. ''We are proud of what we have accomplished so far in our Company's transformation, and our people are energized by the opportunities that we see ahead of us.
''There are three pillars that shape the kind of company that we are building. First, we are driven by robust science. Second, we accept no middle ground when it comes to product quality. Finally, we believe in fostering a career of craftsmanship, where our people can become experts in their trade. Our new brand identity evolved from these three pillars, and they will continue to shape our future.''
